Elevated classical soluble HLA class I molecules in breast cancer patients are associated with favorable disease outcome

BACKGROUND: T cell recognition of human leukocyte antigen (HLA)-presented peptides plays a central role in immunosurveillance of malignant disease. Besides HLA molecules on cell surfaces, soluble HLA molecules (sHLA) are released in the blood and suggested to impact cellular immune responses. METHODS: Here, we investigate classical sHLA class I (HLA-A, -B, -C) molecules in pretreatment serum from 191 patients, either with invasive breast cancer (BC, n = 140) or with ductal carcinoma in situ (DCIS, n = 51), in relation to clinical parameters and survival with a follow-up time of up to 10 years. RESULTS: Classical sHLA class I serum levels were significantly elevated in patients with DCIS and invasive BC compared to a healthy control cohort. sHLA levels did not differ across molecular subtypes or menopausal status. Of note, higher sHLA class I levels at time of diagnosis were associated with prolonged overall survival independent of age and metastatic status. CONCLUSIONS: The findings of this study reveal first insights on classical sHLA class I molecules in BC patients suggesting an association of higher sHLA class I levels with favorable overall survival that warrants mechanistic investigation and identify sHLA as a potential candidate biomarker for further validation.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-11-20
DOI
https://doi.org/10.1186/s12885-026-17386-0
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Elevated classical soluble HLA class I molecules in breast cancer patients are associated with favorable disease outcome

Dominik Dannehl, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Jonas S. Heitmann et al.
1 links
BMC Cancer
Breast Cancer Treatment Studies
article

Elevated classical soluble HLA class I molecules in breast cancer patients are associated with favorable disease outcome

Dominik Dannehl, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Jonas S. Heitmann, Tobias Engler, Christian Martin Tegeler, Anna Seller, André Koch, Jonas Rieth, Annika Nelde, Juliane S. Walz, Markus Hahn
article en

Abstract

BACKGROUND: T cell recognition of human leukocyte antigen (HLA)-presented peptides plays a central role in immunosurveillance of malignant disease. Besides HLA molecules on cell surfaces, soluble HLA molecules (sHLA) are released in the blood and suggested to impact cellular immune responses. METHODS: Here, we investigate classical sHLA class I (HLA-A, -B, -C) molecules in pretreatment serum from 191 patients, either with invasive breast cancer (BC, n = 140) or with ductal carcinoma in situ (DCIS, n = 51), in relation to clinical parameters and survival with a follow-up time of up to 10 years. RESULTS: Classical sHLA class I serum levels were significantly elevated in patients with DCIS and invasive BC compared to a healthy control cohort. sHLA levels did not differ across molecular subtypes or menopausal status. Of note, higher sHLA class I levels at time of diagnosis were associated with prolonged overall survival independent of age and metastatic status. CONCLUSIONS: The findings of this study reveal first insights on classical sHLA class I molecules in BC patients suggesting an association of higher sHLA class I levels with favorable overall survival that warrants mechanistic investigation and identify sHLA as a potential candidate biomarker for further validation.

BMC CancerVol. 26(1)
German Cancer Research Center (DE), Universitätsklinikum Tübingen (DE), University Children's Hospital Tübingen (DE), University of Tübingen (DE)
Universitätsklinikum Tübingen
Good health and well-being
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon